CDMOs assist biopharmaceutical companies in creating the process development and the manufacturing cycle from start to finish. What are the obstacles that stand in the way of CDMOs from scaling-up?
DécouvrirHow can a pharmaceutical company prepare for the day after its branded drug patent loss?
DécouvrirA pharmaceutical distribution company sought to initiate a Continuous Improvement program throughout their entire Distribution Center network, focusing on Quality, Efficiency, Self-sufficiency and Embedment of CI culture.
DécouvrirTefen supported and helped a medical device company win a tender
DécouvrirThis article explains the different approaches and cost benefits toward quality and audit management programs in today’s regulatory world in the Life Sciences industry
DécouvrirThe article discusses best practices approach towards reaching optimized compliancy in the life sciences industry.
DécouvrirThis article will explore synergies to be gained by optimizing both technology and management practices to create a stronger, more effective risk mitigation program.
DécouvrirDécouvrir
As technological advances change the way society thinks and acts many organizations are working harder without gaining a competitive advantage.
DécouvrirThe pressure on Healthcare budgets is placing Pricing on top of most Life Sciences leaders’ agendas. Tefen provides pricing expertise for our clients.
DécouvrirPharmaceutical legal departments today juggle many risks for their companies and risk mitigation will continue to grow in complexity and importance.
DécouvrirNew challenges, larger global markets, and growing complexity are stressing the need for supply chain planning and risk management in the pharma industry
DécouvrirMinimizing changeovers and maximizing flexibility to market demands – the challenge of reducing lead times for a large generic drug manufacturer
DécouvrirOperational excellence requires a deep commitment and a culture of change. A recent survey shows where pharmaceutical manufacturers stand on the path.
DécouvrirA big pharmaceutical firm, specializing in generics and drug delivery engaged Tefen to increase capacity in their existing operations using lean methodologies.
DécouvrirTreatments supported by sound sales & maximize prescription shares for pharmaceutical products. But is that enough to unfold a drug's full revenue potential?
DécouvrirSwooping on opportunities and making daring moves. Israel Makov, president and CEO during critical years, explains how Teva grew into a world power
DécouvrirBiotech companies contend with unique circumstances yet share many of the problems of broad industry. Benchmarking can be a tool to focus on the real key issues
DécouvrirHow implementation of Tefen’s “LEAN 360” approach can help us shorten the lead time on producing and delivering lenses in order to get competitive advantage
DécouvrirTefen helped leading standardization and implementation processes throughout the company's global operations using the CAPA model and process re-engineering
Découvrir